The opinion in support of the decision being entered today is not binding precedent of the Board. UNITED STATES PATENT AND TRADEMARK OFFICE __________ BEFORE THE BOARD OF PATENT APPEALS AND INTERFERENCES __________ Ex parte BUCHI REDDY REGURI and SUDHAKAR SUNKARI __________ Appeal 2007-0313 Application 10/414,447 Technology Center 1600 __________ Decided: September 6, 2007 __________ Before TONI R. SCHEINER, ERIC GRIMES, and NANCY J. LINCK, Administrative Patent Judges. Opinion by GRIMES, Administrative Patent Judge. Concurring and dissenting opinion by LINCK, Administrative Patent Judge. DECISION ON APPEAL This is an appeal under 35 U.S.C. § 134 involving claims to specific crystal forms of valsartan. The Examiner has rejected the claims as nonenabled, indefinite, anticipated, and obvious. We have jurisdiction under 35 U.S.C. § 6(b). We reverse all of the rejections. BACKGROUND Valsartan is a known compound (Specification ¶ 4) that “is used in the treatment of cardiovascular complaints such as hypertension and heartPage: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Next
Last modified: September 9, 2013